Etoricoxib for arthritis and pain Watson DJ, Bolognese JA, Yu C, et al. 2004. Use of gastroprotective agents and discontinua tions due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. Curr Med Res Opin, 20:1899–908. Wiesenhutter CW, Boice JA, Ko A, et al. 2005. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo- controlled trial. Mayo Clin Proc, 80:470–9. [WHO] World Health Organization. 2004. World health report 2004 – changing history [online]. Accessed 27 June 2005. URL: http:// www.who.int/whr/2004/en/index.html. [WHO] World Health Organization. 2005. Chronic rheumatic conditions [online]. Accessed 4 March 2005. URL: http://www.who.int/chp/ topics/rheumatic/en/. Zacher J, Feldman D, Gerli R, et al. 2003. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin, 19:725–36. Zerbini C, Ozturk ZE, Grifka J, et al. 2005. Efficacy of etoricoxib 60mg/ day and diclofenac 150mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized, double-blind study. Curr Med Res Opin, 21:2037–49. Therapeutics and Clinical Risk Management 2006:2(1) 57